No abstract available
Keywords:
Chronic hepatitis C; Direct acting antivirals; Guidelines; Treatment.
Publication types
-
Practice Guideline
-
Review
MeSH terms
-
Benzimidazoles / adverse effects
-
Benzimidazoles / metabolism
-
Benzimidazoles / therapeutic use
-
Carbamates
-
Dose-Response Relationship, Drug
-
Drug Interactions
-
Fluorenes / adverse effects
-
Fluorenes / metabolism
-
Fluorenes / therapeutic use
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Imidazoles / adverse effects
-
Imidazoles / metabolism
-
Imidazoles / therapeutic use
-
Isoquinolines / adverse effects
-
Isoquinolines / metabolism
-
Isoquinolines / therapeutic use
-
Kidney / drug effects
-
Kidney / physiology
-
Protease Inhibitors / adverse effects
-
Protease Inhibitors / metabolism
-
Protease Inhibitors / therapeutic use*
-
Pyrrolidines
-
Sofosbuvir / adverse effects
-
Sofosbuvir / metabolism
-
Sofosbuvir / therapeutic use
-
Sulfonamides / adverse effects
-
Sulfonamides / metabolism
-
Sulfonamides / therapeutic use
-
Valine / analogs & derivatives
Substances
-
Benzimidazoles
-
Carbamates
-
Fluorenes
-
Imidazoles
-
Isoquinolines
-
Protease Inhibitors
-
Pyrrolidines
-
Sulfonamides
-
ledipasvir
-
Valine
-
daclatasvir
-
asunaprevir
-
Sofosbuvir